With a deep understanding of cancer biology, BC is subdivided into four molecular subtypes (luminal A, luminal B, HER2, and TNBC) based on the expression of the estrogen receptor (ER), progesterone receptor (PR), HER2 receptor, and Ki-67 (Abreu et al., 2020). Here, PGR is linked to cancer.